PubMed Health⌕ Search

PubMed · 8917299

Epilepsy education: a nursing perspective.

Abstract

The nurse-clinician offers a unique perspective in the early education of patients with epilepsy. As part of the health-care team, the nurse assumes an important role in providing comprehensive epilepsy education. Epilepsy may occur at any time throughout life, and age-related needs necessitate ongoing assessment and intervention. The initial approach is to formulate an individualized educational plan of care. Financial, emotional, and cultural concerns should be discussed, and available support systems should be analyzed. The goal of epilepsy education is to provide the patient and family members with the informational tools needed to enhance their knowledge about epilepsy. The nurse can present a formal educational plan and schedule appointments to review the various aspects of self-management and reinforce their importance. Ultimately, this knowledge of epilepsy and the recommended treatment plan can lead to a greater sense of power and control necessary for self-management and an improved quality of life. By creating a foundation of trust with the patient, health-care providers can continue to monitor and manage the seizure disorder to attain optimal patient outcomes. This positive interaction with the health-care team will subsequently influence the patient's lifestyle in a beneficial manner.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S V Hausman, R R Luckstein, A M Zwygart, K M Cicora, V M Schroeder, O M Weinhold. 1996. Epilepsy education: a nursing perspective.. https://doi.org/10.4065/71.11.1114

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Long-term seizure outcomes and factors associated with response to adjunctive everolimus in TSC-associated epilepsy.

BACKGROUND: Everolimus, a mechanistic target of rapamycin (mTOR) inhibitor, is increasingly used in tuberous sclerosis complex (TSC)-associated epilepsy; however, long-term real-world outcomes and factors associated with favorable response remain unclear. This study aimed to evaluate the long-term seizure outcomes of adjunctive everolimus and explore clinical factors associated with treatment response. METHODS: We retrospectively recruited 21 patients with active TSC-associated epilepsy receiving adjunctive everolimus and assessed seizure outcomes during follow-up. Clinical characteristics were compared between responders and non-responders at 1 year after treatment initiation. RESULTS: Over a median treatment duration of 72 months, responder rates ranged from 53.8% to 64.7%, and seizure-free rates ranged from 33.3% to 41.2%. Responders had fewer involved organ systems at baseline (median 3 vs. 4, p = 0.020) and lower anti-seizure medication burden (median 2 vs. 4, p = 0.045). Younger age at treatment initiation showed a trend toward improved response. CONCLUSION: Adjunctive everolimus was associated with sustained long-term seizure reduction in this real-world cohort. In exploratory analyses, fewer involved organ systems and fewer baseline ASMs were associated with favorable treatment response. These findings require validation in larger prospective cohorts.

Epilepsy↗